Gene Symbol | Gene ID | Gene Info |
---|---|---|
NR6A1
|
ENSG00000148200.12 | nuclear receptor subfamily 6 group A member 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_127536416_127536567 | NR6A1 | 2902 | 0.179622 | 0.88 | 1.9e-03 | Click! |
chr9_127316512_127316663 | NR6A1 | 41500 | 0.123718 | -0.77 | 1.4e-02 | Click! |
chr9_127336792_127336943 | NR6A1 | 21220 | 0.164299 | -0.75 | 1.9e-02 | Click! |
chr9_127314112_127314350 | NR6A1 | 43856 | 0.118728 | -0.68 | 4.3e-02 | Click! |
chr9_127314557_127314840 | NR6A1 | 43389 | 0.119713 | -0.68 | 4.4e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_72947953_72948226 | 0.35 |
RGS6 |
regulator of G-protein signaling 6 |
21712 |
0.28 |
chrX_13108038_13108679 | 0.33 |
FAM9C |
family with sequence similarity 9, member C |
45557 |
0.18 |
chr9_123652141_123652292 | 0.32 |
PHF19 |
PHD finger protein 19 |
12610 |
0.18 |
chr17_72751609_72751889 | 0.31 |
SLC9A3R1 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
6393 |
0.1 |
chr8_82019930_82020142 | 0.29 |
PAG1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
4267 |
0.34 |
chr1_8488032_8488525 | 0.29 |
RP5-1115A15.1 |
|
2580 |
0.27 |
chr15_40596685_40596954 | 0.29 |
PLCB2 |
phospholipase C, beta 2 |
3207 |
0.11 |
chr21_45509890_45510158 | 0.28 |
PWP2 |
PWP2 periodic tryptophan protein homolog (yeast) |
17147 |
0.16 |
chr10_129860224_129860381 | 0.27 |
PTPRE |
protein tyrosine phosphatase, receptor type, E |
14468 |
0.26 |
chr1_197360685_197361146 | 0.27 |
CRB1 |
crumbs homolog 1 (Drosophila) |
22044 |
0.23 |
chr19_12775707_12775982 | 0.27 |
MAN2B1 |
mannosidase, alpha, class 2B, member 1 |
1704 |
0.14 |
chr1_32825530_32825738 | 0.25 |
FAM229A |
family with sequence similarity 229, member A |
1791 |
0.22 |
chr7_148325963_148326351 | 0.25 |
C7orf33 |
chromosome 7 open reading frame 33 |
38500 |
0.16 |
chr15_86128935_86129221 | 0.24 |
RP11-815J21.2 |
|
5669 |
0.19 |
chr9_22075219_22075414 | 0.24 |
CDKN2B-AS1 |
CDKN2B antisense RNA 1 |
28566 |
0.18 |
chr11_67173722_67173982 | 0.24 |
TBC1D10C |
TBC1 domain family, member 10C |
2192 |
0.12 |
chr2_143898363_143898928 | 0.24 |
ARHGAP15 |
Rho GTPase activating protein 15 |
11762 |
0.25 |
chr8_134528898_134529424 | 0.23 |
ST3GAL1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
17535 |
0.28 |
chr9_92151633_92152777 | 0.23 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
39160 |
0.16 |
chr1_206755327_206755741 | 0.23 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
25041 |
0.13 |
chr1_54946013_54946309 | 0.23 |
ENSG00000265404 |
. |
24180 |
0.16 |
chr3_16556525_16556706 | 0.22 |
RFTN1 |
raftlin, lipid raft linker 1 |
1082 |
0.63 |
chr16_17545376_17545755 | 0.22 |
XYLT1 |
xylosyltransferase I |
19173 |
0.3 |
chr1_206747367_206748212 | 0.22 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
17296 |
0.15 |
chr17_14233383_14233629 | 0.21 |
HS3ST3B1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 |
29106 |
0.23 |
chr3_46411481_46411895 | 0.21 |
CCR5 |
chemokine (C-C motif) receptor 5 (gene/pseudogene) |
55 |
0.97 |
chr18_60806585_60806736 | 0.21 |
RP11-299P2.1 |
|
11893 |
0.25 |
chr6_90981736_90981993 | 0.21 |
BACH2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
24597 |
0.22 |
chr2_136895658_136895809 | 0.21 |
CXCR4 |
chemokine (C-X-C motif) receptor 4 |
19998 |
0.26 |
chr9_117701644_117701992 | 0.21 |
TNFSF8 |
tumor necrosis factor (ligand) superfamily, member 8 |
9121 |
0.28 |
chrX_13102950_13103119 | 0.21 |
FAM9C |
family with sequence similarity 9, member C |
40233 |
0.19 |
chr1_111421634_111421896 | 0.21 |
CD53 |
CD53 molecule |
5989 |
0.21 |
chr21_32736198_32736388 | 0.21 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
19699 |
0.27 |
chr1_209925627_209925957 | 0.21 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
3585 |
0.18 |
chr4_143622207_143622596 | 0.21 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
140579 |
0.05 |
chr5_118645803_118646226 | 0.20 |
ENSG00000243333 |
. |
3688 |
0.25 |
chr9_134146913_134147198 | 0.20 |
FAM78A |
family with sequence similarity 78, member A |
1145 |
0.48 |
chr2_196423126_196423304 | 0.20 |
SLC39A10 |
solute carrier family 39 (zinc transporter), member 10 |
17486 |
0.24 |
chrX_20458891_20459042 | 0.20 |
ENSG00000252978 |
. |
11260 |
0.3 |
chrX_40138916_40139203 | 0.20 |
ENSG00000238920 |
. |
5290 |
0.32 |
chr3_187696963_187697463 | 0.20 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
173859 |
0.03 |
chr15_60836979_60837190 | 0.20 |
CTD-2501E16.2 |
|
14912 |
0.19 |
chr8_71275992_71276158 | 0.20 |
ENSG00000207036 |
. |
6493 |
0.25 |
chrX_134518932_134519216 | 0.20 |
ZNF449 |
zinc finger protein 449 |
40353 |
0.13 |
chr18_43620867_43621135 | 0.20 |
PSTPIP2 |
proline-serine-threonine phosphatase interacting protein 2 |
31222 |
0.13 |
chr10_22899051_22899369 | 0.20 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
18568 |
0.27 |
chr15_85141859_85142174 | 0.20 |
ZSCAN2 |
zinc finger and SCAN domain containing 2 |
2201 |
0.19 |
chrX_135848042_135848429 | 0.20 |
ARHGEF6 |
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
1267 |
0.45 |
chr9_130623880_130624317 | 0.19 |
ENG |
endoglin |
7063 |
0.08 |
chr17_27228319_27228798 | 0.19 |
DHRS13 |
dehydrogenase/reductase (SDR family) member 13 |
1425 |
0.19 |
chr18_60880832_60881273 | 0.19 |
ENSG00000238988 |
. |
19154 |
0.21 |
chr17_33543338_33543516 | 0.19 |
RP11-799D4.4 |
|
21573 |
0.11 |
chr11_67173408_67173659 | 0.19 |
TBC1D10C |
TBC1 domain family, member 10C |
1873 |
0.13 |
chr11_128608264_128608441 | 0.19 |
FLI1 |
Fli-1 proto-oncogene, ETS transcription factor |
26333 |
0.17 |
chr10_11224652_11224918 | 0.19 |
RP3-323N1.2 |
|
11446 |
0.22 |
chr16_27240742_27240893 | 0.19 |
NSMCE1 |
non-SMC element 1 homolog (S. cerevisiae) |
3582 |
0.21 |
chr10_7233978_7234351 | 0.19 |
SFMBT2 |
Scm-like with four mbt domains 2 |
216543 |
0.02 |
chr17_3863445_3863626 | 0.19 |
ATP2A3 |
ATPase, Ca++ transporting, ubiquitous |
4050 |
0.22 |
chr4_143617070_143617312 | 0.19 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
135369 |
0.06 |
chr1_11789201_11789352 | 0.19 |
AGTRAP |
angiotensin II receptor-associated protein |
6865 |
0.13 |
chr2_240219157_240219354 | 0.19 |
ENSG00000265215 |
. |
7902 |
0.19 |
chr1_232715110_232715328 | 0.19 |
SIPA1L2 |
signal-induced proliferation-associated 1 like 2 |
17915 |
0.28 |
chr20_31554218_31554478 | 0.19 |
EFCAB8 |
EF-hand calcium binding domain 8 |
6697 |
0.17 |
chr1_206945881_206946032 | 0.19 |
IL10 |
interleukin 10 |
117 |
0.96 |
chr1_159037154_159037495 | 0.19 |
ENSG00000265589 |
. |
8285 |
0.18 |
chr16_85342323_85342695 | 0.19 |
ENSG00000266307 |
. |
2578 |
0.35 |
chr1_169575119_169575302 | 0.19 |
SELP |
selectin P (granule membrane protein 140kDa, antigen CD62) |
13247 |
0.2 |
chrX_42259008_42259366 | 0.19 |
ENSG00000206896 |
. |
225549 |
0.02 |
chr10_11203289_11203522 | 0.19 |
CELF2 |
CUGBP, Elav-like family member 2 |
3588 |
0.26 |
chr2_28570986_28571140 | 0.19 |
AC093690.1 |
|
37737 |
0.13 |
chr1_167602468_167602965 | 0.18 |
RP3-455J7.4 |
|
2805 |
0.25 |
chr7_50257067_50257311 | 0.18 |
AC020743.2 |
|
74770 |
0.1 |
chr4_6920362_6920560 | 0.18 |
TBC1D14 |
TBC1 domain family, member 14 |
8486 |
0.18 |
chr14_91855068_91855898 | 0.18 |
CCDC88C |
coiled-coil domain containing 88C |
28207 |
0.19 |
chr20_47782632_47782783 | 0.18 |
STAU1 |
staufen double-stranded RNA binding protein 1 |
8093 |
0.21 |
chr5_130731828_130731979 | 0.18 |
CDC42SE2 |
CDC42 small effector 2 |
10604 |
0.3 |
chr6_52200307_52200580 | 0.18 |
PAQR8 |
progestin and adipoQ receptor family member VIII |
25776 |
0.19 |
chr1_12231932_12232095 | 0.18 |
TNFRSF1B |
tumor necrosis factor receptor superfamily, member 1B |
4953 |
0.18 |
chr16_28622056_28622448 | 0.18 |
SULT1A1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
899 |
0.46 |
chr3_60090466_60090753 | 0.18 |
NPCDR1 |
nasopharyngeal carcinoma, down-regulated 1 |
133026 |
0.06 |
chr6_41170433_41170835 | 0.18 |
TREML2 |
triggering receptor expressed on myeloid cells-like 2 |
1702 |
0.26 |
chr9_130473685_130473878 | 0.18 |
C9orf117 |
chromosome 9 open reading frame 117 |
388 |
0.73 |
chr17_75925692_75925843 | 0.18 |
ENSG00000238898 |
. |
9587 |
0.22 |
chr12_53602242_53602592 | 0.18 |
ITGB7 |
integrin, beta 7 |
1326 |
0.29 |
chr12_64992774_64993476 | 0.18 |
RP11-338E21.1 |
|
10114 |
0.13 |
chr11_128162482_128162771 | 0.18 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
212663 |
0.02 |
chr13_41176876_41177104 | 0.18 |
FOXO1 |
forkhead box O1 |
63744 |
0.11 |
chr12_92756626_92757039 | 0.18 |
RP11-693J15.4 |
|
58475 |
0.12 |
chr10_26745731_26745940 | 0.18 |
APBB1IP |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
18481 |
0.24 |
chr3_56823289_56823680 | 0.18 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
12493 |
0.28 |
chr5_131744783_131745111 | 0.18 |
C5orf56 |
chromosome 5 open reading frame 56 |
1381 |
0.32 |
chr21_44819666_44819955 | 0.18 |
SIK1 |
salt-inducible kinase 1 |
27198 |
0.24 |
chr10_6585736_6586147 | 0.18 |
PRKCQ |
protein kinase C, theta |
36260 |
0.23 |
chr6_41975005_41975289 | 0.18 |
ENSG00000206875 |
. |
11105 |
0.16 |
chr6_14373007_14373158 | 0.18 |
ENSG00000238987 |
. |
216389 |
0.02 |
chr13_95836619_95836770 | 0.18 |
ENSG00000238463 |
. |
25904 |
0.23 |
chr1_229170121_229170313 | 0.18 |
RP5-1061H20.5 |
|
193092 |
0.02 |
chr1_65330970_65331121 | 0.18 |
RAVER2 |
ribonucleoprotein, PTB-binding 2 |
87298 |
0.09 |
chr2_234177577_234177728 | 0.18 |
ENSG00000252010 |
. |
6721 |
0.15 |
chr5_75770152_75770552 | 0.18 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
70103 |
0.12 |
chr6_53109375_53109667 | 0.18 |
ENSG00000206908 |
. |
25462 |
0.15 |
chr19_7411370_7411784 | 0.18 |
CTB-133G6.1 |
|
2271 |
0.26 |
chr1_112054315_112054681 | 0.18 |
ADORA3 |
adenosine A3 receptor |
8116 |
0.13 |
chr2_60780651_60780821 | 0.18 |
BCL11A |
B-cell CLL/lymphoma 11A (zinc finger protein) |
34 |
0.98 |
chr10_6583895_6584058 | 0.18 |
PRKCQ |
protein kinase C, theta |
38225 |
0.22 |
chr10_11193217_11193852 | 0.18 |
CELF2 |
CUGBP, Elav-like family member 2 |
13459 |
0.2 |
chr14_24807724_24807962 | 0.18 |
RIPK3 |
receptor-interacting serine-threonine kinase 3 |
1235 |
0.19 |
chr21_36401379_36401530 | 0.18 |
RUNX1 |
runt-related transcription factor 1 |
20008 |
0.29 |
chr8_103121247_103121419 | 0.18 |
NCALD |
neurocalcin delta |
14845 |
0.21 |
chr6_52241496_52241889 | 0.18 |
PAQR8 |
progestin and adipoQ receptor family member VIII |
14448 |
0.22 |
chrX_70318458_70318852 | 0.17 |
FOXO4 |
forkhead box O4 |
2276 |
0.17 |
chr5_76152388_76152629 | 0.17 |
S100Z |
S100 calcium binding protein Z |
6584 |
0.18 |
chr17_38760477_38760676 | 0.17 |
SMARCE1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 |
27966 |
0.12 |
chr6_24962302_24962654 | 0.17 |
FAM65B |
family with sequence similarity 65, member B |
26290 |
0.19 |
chr8_145085888_145086183 | 0.17 |
SPATC1 |
spermatogenesis and centriole associated 1 |
547 |
0.47 |
chr13_110222272_110222771 | 0.17 |
LINC00676 |
long intergenic non-protein coding RNA 676 |
158108 |
0.04 |
chr1_27165220_27165588 | 0.17 |
ZDHHC18 |
zinc finger, DHHC-type containing 18 |
6893 |
0.12 |
chr3_52303914_52304065 | 0.17 |
ENSG00000199150 |
. |
1610 |
0.2 |
chr8_131025939_131026245 | 0.17 |
FAM49B |
family with sequence similarity 49, member B |
2559 |
0.24 |
chr19_13993263_13993689 | 0.17 |
NANOS3 |
nanos homolog 3 (Drosophila) |
5413 |
0.09 |
chr4_129783038_129783517 | 0.17 |
JADE1 |
jade family PHD finger 1 |
30689 |
0.24 |
chr1_100830416_100830661 | 0.17 |
CDC14A |
cell division cycle 14A |
12033 |
0.18 |
chr3_187676645_187676932 | 0.17 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
194284 |
0.03 |
chr4_99367280_99367535 | 0.17 |
RP11-724M22.1 |
|
50108 |
0.16 |
chr17_74148395_74148576 | 0.17 |
RNF157-AS1 |
RNF157 antisense RNA 1 |
1308 |
0.31 |
chr3_16880178_16880359 | 0.17 |
PLCL2 |
phospholipase C-like 2 |
46184 |
0.18 |
chr14_104855874_104856139 | 0.17 |
ENSG00000222761 |
. |
11379 |
0.26 |
chr2_109833807_109834002 | 0.17 |
ENSG00000264934 |
. |
75860 |
0.1 |
chr20_5623012_5623187 | 0.17 |
GPCPD1 |
glycerophosphocholine phosphodiesterase GDE1 homolog (S. cerevisiae) |
31427 |
0.21 |
chr7_69068510_69068661 | 0.17 |
AUTS2 |
autism susceptibility candidate 2 |
3988 |
0.32 |
chr19_39107432_39107629 | 0.17 |
MAP4K1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
1034 |
0.37 |
chr11_110709081_110709232 | 0.17 |
ARHGAP20 |
Rho GTPase activating protein 20 |
125244 |
0.06 |
chr3_177662901_177663156 | 0.17 |
ENSG00000199858 |
. |
62539 |
0.16 |
chr14_61909696_61909971 | 0.17 |
PRKCH |
protein kinase C, eta |
557 |
0.83 |
chr8_19554391_19555213 | 0.17 |
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
14530 |
0.29 |
chr4_4420478_4420740 | 0.17 |
NSG1 |
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
31777 |
0.16 |
chr19_16229174_16229347 | 0.17 |
RAB8A |
RAB8A, member RAS oncogene family |
6553 |
0.14 |
chr9_92056751_92057221 | 0.17 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
5588 |
0.27 |
chr1_160579528_160579679 | 0.17 |
CD84 |
CD84 molecule |
30297 |
0.12 |
chr10_11237002_11237580 | 0.17 |
RP3-323N1.2 |
|
23952 |
0.2 |
chr2_191934456_191934744 | 0.17 |
ENSG00000231858 |
. |
48348 |
0.11 |
chr6_15264518_15264669 | 0.17 |
JARID2 |
jumonji, AT rich interactive domain 2 |
15450 |
0.18 |
chr18_2960888_2961200 | 0.17 |
RP11-737O24.1 |
|
5972 |
0.16 |
chr5_55387236_55387387 | 0.17 |
ANKRD55 |
ankyrin repeat domain 55 |
25467 |
0.16 |
chr5_67674468_67674625 | 0.17 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
86150 |
0.1 |
chr3_16942822_16942973 | 0.17 |
PLCL2 |
phospholipase C-like 2 |
16445 |
0.23 |
chr4_90208438_90208788 | 0.17 |
GPRIN3 |
GPRIN family member 3 |
20548 |
0.27 |
chr10_6603625_6603862 | 0.17 |
PRKCQ |
protein kinase C, theta |
18458 |
0.29 |
chr1_69963453_69963604 | 0.17 |
LRRC7 |
leucine rich repeat containing 7 |
70553 |
0.14 |
chr2_101946285_101946451 | 0.17 |
ENSG00000264857 |
. |
20456 |
0.16 |
chr8_129664945_129665222 | 0.17 |
ENSG00000221351 |
. |
166957 |
0.04 |
chr1_108741850_108742080 | 0.16 |
RP11-483I13.5 |
|
583 |
0.61 |
chr10_17469337_17469935 | 0.16 |
ST8SIA6-AS1 |
ST8SIA6 antisense RNA 1 |
19610 |
0.17 |
chr9_20228261_20228412 | 0.16 |
ENSG00000221744 |
. |
66666 |
0.13 |
chr4_109275787_109275938 | 0.16 |
ENSG00000232021 |
. |
178418 |
0.03 |
chr7_50301548_50301699 | 0.16 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
42701 |
0.19 |
chr14_90147407_90147667 | 0.16 |
ENSG00000252655 |
. |
30290 |
0.14 |
chr12_57456902_57457053 | 0.16 |
MYO1A |
myosin IA |
12018 |
0.1 |
chr1_208045857_208046008 | 0.16 |
CD34 |
CD34 molecule |
17905 |
0.25 |
chr16_21658961_21659187 | 0.16 |
IGSF6 |
immunoglobulin superfamily, member 6 |
4853 |
0.13 |
chr1_17759092_17759354 | 0.16 |
RCC2 |
regulator of chromosome condensation 2 |
5834 |
0.17 |
chr16_31488982_31489389 | 0.16 |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
4438 |
0.1 |
chr12_781338_781694 | 0.16 |
NINJ2 |
ninjurin 2 |
8571 |
0.19 |
chr11_306863_307074 | 0.16 |
IFITM2 |
interferon induced transmembrane protein 2 |
663 |
0.42 |
chr9_80622373_80622560 | 0.16 |
GNAQ |
guanine nucleotide binding protein (G protein), q polypeptide |
23054 |
0.27 |
chr12_76934517_76934736 | 0.16 |
OSBPL8 |
oxysterol binding protein-like 8 |
18658 |
0.28 |
chr7_150374566_150375043 | 0.16 |
GIMAP2 |
GTPase, IMAP family member 2 |
7984 |
0.18 |
chr14_93124277_93124612 | 0.16 |
RIN3 |
Ras and Rab interactor 3 |
5598 |
0.29 |
chr16_3126091_3126264 | 0.16 |
ENSG00000252561 |
. |
6653 |
0.06 |
chr12_12626467_12626673 | 0.16 |
DUSP16 |
dual specificity phosphatase 16 |
47489 |
0.15 |
chr5_175956521_175957004 | 0.16 |
RNF44 |
ring finger protein 44 |
884 |
0.47 |
chr5_75685944_75686439 | 0.16 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
12883 |
0.27 |
chr19_6654326_6654734 | 0.16 |
TNFSF14 |
tumor necrosis factor (ligand) superfamily, member 14 |
15598 |
0.13 |
chr2_135425836_135426057 | 0.16 |
TMEM163 |
transmembrane protein 163 |
50624 |
0.17 |
chr15_93579557_93579854 | 0.16 |
CHD2 |
chromodomain helicase DNA binding protein 2 |
27609 |
0.2 |
chr2_106370179_106370624 | 0.16 |
NCK2 |
NCK adaptor protein 2 |
8213 |
0.3 |
chr19_7458115_7458266 | 0.16 |
CTB-133G6.2 |
|
1735 |
0.24 |
chr12_68848636_68848957 | 0.16 |
MDM1 |
Mdm1 nuclear protein homolog (mouse) |
122635 |
0.05 |
chr2_220112096_220112414 | 0.16 |
STK16 |
serine/threonine kinase 16 |
1637 |
0.15 |
chr14_51711081_51711357 | 0.16 |
ENSG00000201376 |
. |
411 |
0.84 |
chr15_41735495_41735646 | 0.16 |
ENSG00000200407 |
. |
5472 |
0.16 |
chr7_26410221_26410372 | 0.16 |
AC004540.4 |
|
5596 |
0.24 |
chr7_7199791_7199942 | 0.16 |
C1GALT1 |
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 |
3301 |
0.25 |
chrX_41969111_41969315 | 0.16 |
ENSG00000212560 |
. |
29570 |
0.22 |
chr12_111888335_111888486 | 0.16 |
ATXN2 |
ataxin 2 |
5506 |
0.19 |
chr1_207244347_207244498 | 0.16 |
PFKFB2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
6073 |
0.14 |
chr10_22422484_22422726 | 0.16 |
EBLN1 |
endogenous Bornavirus-like nucleoprotein 1 |
76345 |
0.1 |
chr19_56143009_56143160 | 0.16 |
ZNF580 |
zinc finger protein 580 |
3298 |
0.09 |
chr3_71277170_71277635 | 0.16 |
FOXP1 |
forkhead box P1 |
16914 |
0.27 |
chr7_72939321_72939472 | 0.16 |
BAZ1B |
bromodomain adjacent to zinc finger domain, 1B |
2788 |
0.21 |
chr9_117136205_117136760 | 0.16 |
AKNA |
AT-hook transcription factor |
2762 |
0.28 |
chr19_54899589_54899740 | 0.16 |
LAIR1 |
leukocyte-associated immunoglobulin-like receptor 1 |
17499 |
0.09 |
chr20_56039749_56039992 | 0.16 |
CTCFL |
CCCTC-binding factor (zinc finger protein)-like |
59443 |
0.1 |
chr6_36139598_36139749 | 0.16 |
BRPF3 |
bromodomain and PHD finger containing, 3 |
24848 |
0.13 |
chr7_148418097_148418248 | 0.16 |
ENSG00000264918 |
. |
9848 |
0.18 |
chr1_167612000_167612291 | 0.16 |
RP3-455J7.4 |
|
12234 |
0.19 |
chrX_16612049_16612225 | 0.16 |
ENSG00000265144 |
. |
33071 |
0.16 |
chr3_105904284_105904435 | 0.16 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
315963 |
0.01 |
chr16_23868832_23868983 | 0.16 |
PRKCB |
protein kinase C, beta |
20363 |
0.23 |
chr11_73691666_73692195 | 0.16 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
53 |
0.97 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.3 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 0.4 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.1 | 0.3 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.1 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.1 | 0.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.2 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.1 | GO:0002666 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.0 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.0 | 0.6 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.1 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.0 | 0.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.0 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.2 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.0 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.0 | 0.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.1 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.0 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.4 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.0 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.0 | 0.1 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.0 | 0.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.0 | 0.1 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.4 | GO:0000303 | response to superoxide(GO:0000303) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.0 | GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.5 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.0 | GO:0071801 | regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.2 | GO:0002714 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.0 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.0 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.0 | 0.1 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.0 | 0.0 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.0 | 0.0 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.0 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.1 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.1 | GO:0061647 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.1 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.0 | 0.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.0 | 0.1 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.1 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.0 | 0.1 | GO:0030540 | female genitalia development(GO:0030540) |
0.0 | 0.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.4 | GO:0050868 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.0 | 0.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.1 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.0 | GO:0045978 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.0 | 0.0 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.0 | 0.1 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.0 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.0 | 0.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.1 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.0 | 0.1 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.0 | 0.0 | GO:0070602 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.1 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.0 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0072182 | nephron tubule epithelial cell differentiation(GO:0072160) regulation of nephron tubule epithelial cell differentiation(GO:0072182) regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.0 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.1 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.0 | 0.0 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.0 | 0.4 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.0 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.0 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.0 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.0 | 0.0 | GO:0070933 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.0 | 0.1 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.0 | 0.0 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.0 | 0.0 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.0 | 0.0 | GO:0031060 | regulation of histone methylation(GO:0031060) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.0 | GO:0097300 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.0 | 0.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.0 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.0 | GO:1903077 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.0 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.0 | 0.0 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.0 | GO:0098754 | detoxification(GO:0098754) |
0.0 | 0.1 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.0 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.0 | 0.0 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.0 | 0.0 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.0 | 0.0 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.1 | GO:0021561 | facial nerve development(GO:0021561) |
0.0 | 0.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0016265 | obsolete death(GO:0016265) |
0.0 | 0.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.0 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.0 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.1 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.0 | GO:0002369 | T cell cytokine production(GO:0002369) positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.2 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.0 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.0 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.0 | 0.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.0 | GO:0090201 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.0 | GO:2000192 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.0 | 0.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.0 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.0 | 0.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.0 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.0 | 0.0 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.0 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.2 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.0 | 0.1 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.0 | 0.2 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.0 | 0.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.0 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.0 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.0 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.0 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.0 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.1 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.1 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 0.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.3 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.0 | 0.0 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.2 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0000145 | exocyst(GO:0000145) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.3 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 0.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.1 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.1 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.0 | 1.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.0 | 0.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.0 | 0.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.0 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.3 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.0 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0004340 | glucokinase activity(GO:0004340) |
0.0 | 0.0 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.0 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.2 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.1 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.2 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 0.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.0 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 1.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.1 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.1 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 0.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |